Life Sciences IPO Boom Leaves Out Medical Devices (WSJ Blogs)
Biotechnology startups have stampeded to the public markets this year, but their colleagues in the medical device field have sat quietly on the sidelines.
So far this year, 27 venture-backed biopharmaceutical companies have gone public, compared to just one medical device company, according to industry tracker Dow Jones VentureSource.
While biopharmas generally go public in greater numbers than medical device companies, the spread has never been this great–in 2007, for example, 19 biopharmas went public, compared to 10 medical devic...